Immobilization hypercalcemia in incomplete paraplegia: Successful treatment with pamidronate

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 2, 1998, Pages 222-225

  Kedlaya, Divakara ^a   Brandstater, Murray E ^a   Lee, Jonathan K ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CLODRONIC ACID; CORTICOSTEROID; DIURETIC AGENT; ETIDRONIC ACID; GABAPENTIN; MITHRAMYCIN; NARCOTIC ANALGESIC AGENT; PAMIDRONIC ACID; SALCATONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; FEVER; GASTROINTESTINAL SYMPTOM; GUNSHOT INJURY; HUMAN; HYPERCALCEMIA; IMMOBILIZATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NEUROLOGICAL COMPLICATION; PAIN; PARALYSIS; PARAPLEGIA; SPINAL CORD INJURY; SUBCUTANEOUS DRUG ADMINISTRATION; TRAFFIC ACCIDENT; WOUND INFECTION;

EID: 0031930512     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90304-5     Document Type: Article

References (30)

1. Albright F, Burnett CH, Cope O, Parson W. Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism. J Clin Endocrinol 1941;1:711-6.
2. Claus-Walker J, Carter RE, Campos RJ, Spencer WA. Hypercalcemia in early traumatic quadriplegia. J Chron Dis 1975;28:81-90.
3. Tori JA, Hill LL. Hypercalcemia in children with spinal cord injury. Arch Phys Med Rehabil 1978;59:443-7.
4. Maynard FM. Immobilization hypercalcemia following spinal cord injury. Arch Phys Med Rehabil 1986;67:41-4.
5. Gallacher SJ, Ralston SH, Dryburgh SJ, Logue FC, Allam BF, Boyce BF, et al. Immobilization-related hypercalcemia - a possible novel mechanism and response to pamidronate. Postgrad Med J 1990;66:918-22.
6. Tamion E, Bonmarchand F, Girault C, Chevron V, Leroy J. Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia. Clin Nephrol 1995;43:138-9.
7. Varache N, Audran M, Clochon P, Lortholary A, Bouachour G, Alquier P, et al. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient. Clin Rheumatol 1991;10:328-32.
8. Profumo RJ, Reese JC, Foy TM, Garibaldi LR, Kane RE. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate. Transplantation 1994;57:301-3.
9. Mark S. Hypercalcaemia in an immobilised patient with pneumonia. Br J Clin Pract 1995;49:327-9.
10. McIntyre HD, Cameron DP, Urquhart SM, Davies WE. Immobilization hypercalcemia responding to intravenous pamidronate. Postgrad Med J 1989;65:244-6.
11. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: An example of resorptive hypercalciuria. N Engl J Med 1982;306:1136-40.
12. Kaul S, Sockalosky JJ. Human synthetic calcitonin therapy for hypercalcemia of immobilization. J Pediatr 1995;126:825-7.
13. Claus-Walker J, Halstead LS, Rodriguez GP, Henry YK. Spinal cord injury hypercalcemia: therapeutic profile. Arch Phys Med Rehabil 1982;63:108-15.
14. Maynard FM, Imai K. Immobilization hypercalcemia in spinal cord injury. Arch Phys Med Rehabil 1977;58:16-24.
15. Minaire P, Despassio J, Berard E, Meunier PJ, Edouard C, Pilonchery G, et al. Effects of clodronate on immobilization bone loss. Bone 1987;8 Suppl 1:S63-8.
16. Latham BB, Osterman J, Lin T, Nankin HR. Immobilization hypercalcemia in an adult patient with pancreatitis and sepsis: case report. J S C Med Assoc 1992;88:570-2.
17. Anderson H, Bosaeus I, Brummer RJ, Fasth S, Hulten L, Magnusson, et al. Nutritional and metabolic consequences of extensive bowel resection in short bowel syndrome. Dig Dis 1986;4:193-202.
18. Carr CE, Genant HK, Young DR. Comparison of vertebral and peripheral mineral losses in disuse osteoporosis in monkeys. Radiology 1980;134:525-9.
19. Carey DE, Raisz LG. Calcitonin therapy in prolonged immobilization hypercalcemia. Arch Phys Med Rehabil 1985;66:640-4.
20. Monno S, Yokozava T, Mizushima Y, Nakayama J, Ohgaku S, Kato H, et al. Primary hyperparathyroidism masquerading as immobilization hypercalcemia: report of an illustrative case. Endocrine J 1993;40:35-9.
21. Tori JA, Kewelramani LS. Urolithiasis in children with spinal cord injury. Paraplegia 1978;16:357-65.
22. Meythaler JM, Tuel SM, Cross LL. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate. Arch Phys Med Rehabil 1993;74:316-9.
23. Claus-Walker J, Campos RJ, Carter RE, Vallbona C, Lipscomb HS. Calcium excretion in quadreplegia. Arch Phys Med Rehabil 1972; 53:14-20, 37.
24. Merli GJ, McElwain GE, Adler AG, Martin JH, Roberts JD, Schnall B, et al. Immobilization hypercalcemia in acute spinal cord injury treated with etidronate. Arch Intern Med 1984;144:1266-8.
25. Singer FR, Minoofar PN. Bisphosphanates in the treatment of disorders of mineral metabolism. Adv Endocrinol Metab 1995;6:259-88.
26. Kinirons MT. Newer agents for the treatment of malignant hypercalcemia. Am J Med Sci 1993;305:403-6.
27. Fitton A, McTavish D. Pamidronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1991;41:289-318.
28. Ralston SH, Gallagher SJ, Patel U, Dryburgh FJ, Fraser WD, Cowan RA, et al. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcemia. Lancet 1989;2:1180-2.
29. Gallacher SJ, Ralston SH, Patel U, Boyle IT. Side effects of pamidronate. Lancet 1989;2:42-3.
30. Jodrell DI, Iveson TJ, Smith IE. Symptomatic hypocalcemia after treatment with high-dose aminohydroxypropylidene diphosphonate. Lancet 1987;1:622.